menu close
Access The Private Market

Explore Companies

With a comprehensive suite of private market programming and liquidity solutions, Nasdaq Private Market can help unlock the power of data for market participants worldwide.

ADARx Pharmaceuticals

Develops RNA-targeting therapeutics.

Adimab

Operates as an antibody discovery company.

Altopharmacy-Logo

Alto Pharmacy

Distributes medication and uses technology to make the pharmacy experience more convenient for patients.

Ampersand Bio

Develops targeted therapeutics using the AND™ Platform to treat diseases precisely, minimizing side effects and toxicities.

Ankyra

Develops anchored immunotherapies that improve drug efficacy.

Apnimed

Develops oral pharmacologic therapies.

Arbor Biotechnologies

Develops next-generation gene editing therapies using a diverse toolbox of novel gene editors.

Arsenalbio-Logo

ArsenalBio

Develops programmable cell therapies for cancer patients.

Asher Biotherapeutics

Develops targeted immunotherapies for cancer and diseases using a cis-targeting platform.

Attovia Therapeutics-Logo

Attovia

Pipeline of bio-therapeutics with an initial focus on immune-mediated diseases.

Attralus

Developing transformative medicines to improve the lives of patients with systemic amyloidosis.

Avalyn Pharma

Develops inhaled therapies for rare respiratory diseases like idiopathic pulmonary fibrosis and interstitial lung diseases.

Billiontoone-Logo

BillionToOne

Developed a DNA molecular counting technology for detecting gene disorders through a blood test.

Biosplice

Developing small-molecule therapeutics based on pioneering science of alternative pre-mRNA splicing.

BostonGene

Advances personalized medicine and precision oncology by providing insights into the molecular profile of cancer.

Cambrian Bio

Clinical-stage drug development company.

CAMP4

Specializes in programmable RNA-based therapeutics, which aim to provide targeted treatments for a variety of complex diseases.

Capstan Therapeutics-Logo

Capstan

In vivo engineering of cells through targeted lipid nanoparticles.